|
|
Blood, 15 February 2006, Vol. 107, No. 4, pp. 1265-1275.
Prepublished online as a Blood First Edition Paper on October 27, 2005; DOI 10.1182/blood-2005-09-3621.
 Previous Article | Next Article 
Submitted September 9, 2005
Accepted October 9, 2005
Designer blood: creating hematopoietic lineages from embryonic stem cells
Abby L Olsen, David L Stachura, and Mitchell J Weiss*
Cell and Molecular Biology Graduate Program, The University of Pennsylvania School of Medicine, Philadelphia, PA, USA; Combined Degree Graduate Program, The University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Cell and Molecular Biology Graduate Program, The University of Pennsylvania School of Medicine, Philadelphia, PA, USA
The Children's Hospital of Philadelphia, Division of Hematology and the University of Pennsylvania, Philadelphia, PA, USA
* Corresponding author; email: weissmi{at}email.chop.edu.
Embryonic stem (ES) cells exhibit the remarkable capacity to become virtually any differentiated tissue upon appropriate manipulation in culture, a property that has been beneficial for studies of hematopoiesis. Until recently, the majority of this work utilized murine ES cells for basic research to elucidate fundamental properties of blood cell development and establish methods to derive specific mature lineages. Now, the advent of human ES cells sets the stage for more applied pursuits to generate transplantable cells for treating blood disorders. Current efforts are directed toward adapting in vitro hematopoietic differentiation methods developed for murine ES cells to human lines, identifying the key interspecies differences in biological properties of ES cells and overcoming current obstacles to generating ES cell-derived hematopoietic stem cells that are competent to repopulate adult hosts. The ultimate medical goal is to create patient-specific and generic ES cell lines that can be expanded in vitro, genetically altered and differentiated into cell types that can be used to treat hematopoietic diseases.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. L. Stachura, J. R. Reyes, P. Bartunek, B. H. Paw, L. I. Zon, and D. Traver
Zebrafish kidney stromal cell lines support multilineage hematopoiesis
Blood,
July 9, 2009;
114(2):
279 - 289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Woll, B. Grzywacz, X. Tian, R. K. Marcus, D. A. Knorr, M. R. Verneris, and D. S. Kaufman
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
Blood,
June 11, 2009;
113(24):
6094 - 6101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Matsunaga, D. Fukuma, S. Hirata, S. Fukushima, M. Haruta, T. Ikeda, I. Negishi, Y. Nishimura, and S. Senju
Activation of Antigen-Specific Cytotoxic T Lymphocytes by {beta}2-Microglobulin or TAP1 Gene Disruption and the Introduction of Recipient-Matched MHC Class I Gene in Allogeneic Embryonic Stem Cell-Derived Dendritic Cells
J. Immunol.,
November 1, 2008;
181(9):
6635 - 6643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Cameron, F. Harding, W.-S. Hu, and D. S. Kaufman
Activation of Hypoxic Response in Human Embryonic Stem Cell-Derived Embryoid Bodies
Experimental Biology and Medicine,
August 1, 2008;
233(8):
1044 - 1057.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Schneider, E. Wolf, J. Braun, H.-J. Kolb, and H. Adler
Canine embryo-derived stem cells and models for human diseases
Hum. Mol. Genet.,
April 15, 2008;
17(R1):
R42 - R47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Zampetaki, L. Zeng, Q. Xiao, A. Margariti, Y. Hu, and Q. Xu
Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-{alpha} is rescued by HDAC inhibitor trichostatin A
Am J Physiol Cell Physiol,
October 1, 2007;
293(4):
C1226 - C1238.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
